MedPath

昆山龙灯瑞迪制药有限公司

Ownership
-
Established
1993-12-31
Employees
-
Market Cap
-
Website
www.rotamreddy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

37

NMPA:37

Drug Approvals

Dacomitinib Tablets

Product Name
达可替尼片
Approval Number
国药准字H20254268
Approval Date
May 27, 2025
NMPA

Dacomitinib Tablets

Product Name
达可替尼片
Approval Number
国药准字H20254267
Approval Date
May 27, 2025
NMPA

Pazopanib Tablets

Product Name
培唑帕尼片
Approval Number
国药准字H20253053
Approval Date
Jan 2, 2025
NMPA

Beraprost Sodium Tablets

Product Name
贝前列素钠片
Approval Number
国药准字H20249757
Approval Date
Dec 17, 2024
NMPA

Fluvoxamine Maleate Tablets

Product Name
马来酸氟伏沙明片
Approval Number
国药准字H20244742
Approval Date
Aug 27, 2024
NMPA

Dapagliflozin Tablets

Product Name
达格列净片
Approval Number
国药准字H20244737
Approval Date
Aug 27, 2024
NMPA

Dapagliflozin Tablets

Product Name
达格列净片
Approval Number
国药准字H20244736
Approval Date
Aug 27, 2024
NMPA

Fluvoxamine Maleate Tablets

Product Name
马来酸氟伏沙明片
Approval Number
国药准字H20244743
Approval Date
Aug 27, 2024
NMPA

Amlodipine Besylate and Atorvastatin Calcium Tablets

Product Name
氨氯地平阿托伐他汀钙片
Approval Number
国药准字H20243945
Approval Date
Jun 4, 2024
NMPA

Amlodipine Besylate and Atorvastatin Calcium Tablets

Product Name
氨氯地平阿托伐他汀钙片
Approval Number
国药准字H20243383
Approval Date
Jun 4, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.